Fig. 1From: Cost-effectiveness analysis of metformin+dipeptidyl peptidase-4 inhibitors compared to metformin+sulfonylureas for treatment of type 2 diabetesMarkov Model Diagram, Acronyms: DPP-4i-dipeptidyl peptidase-4 inhibitors, SU-sulfonylureasBack to article page